
JHVEPhoto/iStock Editorial via Getty Images
Shares of Teva Pharmaceutical (TEVA) lost nearly 7% on Thursday after the company announced the departure of its R&D head, Eric Hughes, at a time when the generic drugmaker is increasing its focus on its innovative medicines portfolio.
In a
